Germany's Merck Cautious After Deal Spree

Germany’s Merck forecasts little or no improvement in earnings this year, with stiff competition for its blockbuster multiple-sclerosis treatment and higher research spending likely to offset the impact of recent acquisitions.

Topics:  germany s merck   
BING NEWS:
  • As rival Merck monopolizes BCG supply, ImmunityBio taps Serum Institute for new combo's manufacturing
    Now, the California biotech has partnered with the Serum Institute of India in an exclusive deal to manufacture BCG globally ... In the current indication, ImmunityBio will go toe to toe with Merck & ...
    05/2/2024 - 11:50 pm | View Link
  • Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
    The first-quarter results come as Merck shows substantial progress in preparing for Keytruda’s patent expiration in 2028.
    04/24/2024 - 5:33 pm | View Link
  • Mergers and Acquisitions in 2024: A Cautious Recovery With Strategic Shifts
    While the year began with the echoes of previous anxieties—global economic uncertainty, inflation concerns, high-interest rates that increase the cost of capital, and lingering pandemic effects—signs ...
    04/22/2024 - 3:29 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News